risperidone has been researched along with ketamine in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (24.14) | 29.6817 |
| 2010's | 17 (58.62) | 24.3611 |
| 2020's | 5 (17.24) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Duncan, GE; Leipzig, JN; Lieberman, JA; Miyamoto, S | 1 |
| Kato, S; Nisijima, K; Shioda, K; Takano, K; Yoshino, T | 1 |
| Cilia, J; Hatcher, P; Jones, DN; Reavill, C | 1 |
| Becker, A; Grecksch, G; Hiemke, C; Ladstaetter, E; Schmitt, U; Zernig, G | 1 |
| Contreras, D; Ehrlichman, RS; Finkel, LH; Gandal, MJ; Lazarewicz, MT; Maxwell, CR; Siegel, SJ; Turetsky, BI | 1 |
| Chatterjee, M; Ganguly, S; Palit, G; Srivastava, M | 1 |
| Adzu, B; Chindo, BA; Gamaniel, KS; Yahaya, TA | 1 |
| Carvalho, AF; Cordeiro, RC; de Lucena, DF; de Sousa, FC; de Souza, GC; dos Santos, JV; Macêdo, DS; McIntyre, RS; Monte, AS; Ribeiro, BM; Soczynska, JK; Vasconcelos, SM | 1 |
| Dawson, GR; Dourish, CT | 1 |
| Altavilla, A; Craig, KJ; Dawson, GR; Dourish, CT; Ettinger, U; Evans, LH; Koychev, I; Lees, J; Morris, R; Perkins, A; Schmechtig, A; Smallman, R; Walters, J; Weaver, K; Wilkinson, LS; William Deakin, JF; Williams, SC | 1 |
| Brammer, M; Doyle, OM; Joules, R; Mehta, MA; O'Daly, OG; Schwarz, AJ; Williams, SC | 1 |
| de Simoni, S; Doyle, O; Mehta, MA; Schwarz, AJ; Shcherbinin, S; Zelaya, FO | 1 |
| Gopinath, K; Howell, L; Kempf, D; Maltbie, E; Urushino, N | 2 |
| Cordeiro, RC; da Silva Araújo, T; de Freitas Lima, R; de Jesus Souza Machado, M; Freitas de Lucena, D; Isabelle de Góis Queiroz, A; Macêdo, D; Maes, M; Maia Chaves Filho, AJ; Monte, AS | 1 |
| Aderibigbe, AO; Ajayi, AM; Ben-Azu, B; Iwalewa, EO; Omogbiya, IA; Umukoro, S | 1 |
| Aderibigbe, AO; Ajayi, AM; Ben-Azu, B; Eneni, AO; Iwalewa, EO; Umukoro, S | 1 |
| Ahrens, PS; Gallagher, M; Koh, MT | 1 |
| Bakker, IM; Kamphuis, J; Schoevers, RA; Smith-Apeldoorn, SY; Touw, DJ; Veraart, JKE; Visser, BAE | 1 |
| Azimi Sanavi, M; Ghalehnoei, H; Ghazvini, H; Hosseini-Khah, Z; Zargari, M | 1 |
| Erdinc, M; Eriman, H; Kelle, I; Uyar, E | 1 |
| Carter, B; Cleare, AJ; Emre, C; Gnanapragasam, S; Hampsey, E; Korotkova, L; Martín-Dombrowski, J; Marwood, L; Scott, F; Strawbridge, R; Taylor, RW; Young, AH | 1 |
| Agu, GO; Ajayi, AM; Akaenyi, DE; Ben-Azu, B; Chijioke, BS; Chilaka, KC; Edigbue, NL; Esiekpe, UV; Jarikre, TA; Nwangwa, KE; Ofili, EC; Omonyeme, MG; Ozege, CB; Uruaka, CI; Warekoromor, EB | 1 |
3 review(s) available for risperidone and ketamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacodynamic Interactions Between Ketamine and Psychiatric Medications Used in the Treatment of Depression: A Systematic Review.
Topics: Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Depression; Drug Interactions; Female; Haloperidol; Humans; Ketamine; Lithium; Male; Olanzapine; Psychotropic Drugs; Risperidone; Schizophrenia; Treatment Outcome | 2021 |
Systematic review and meta-analysis of augmentation and combination treatments for early-stage treatment-resistant depression.
Topics: Adult; Aripiprazole; Depression; Depressive Disorder, Major; Humans; Ketamine; Risperidone | 2023 |
2 trial(s) available for risperidone and ketamine
| Article | Year |
|---|---|
The effects of ketamine and risperidone on eye movement control in healthy volunteers.
Topics: Adolescent; Adult; Antipsychotic Agents; Double-Blind Method; Excitatory Amino Acid Antagonists; Eye Movement Measurements; Eye Movements; Female; Healthy Volunteers; Humans; Ketamine; Male; Ocular Motility Disorders; Pursuit, Smooth; Receptors, N-Methyl-D-Aspartate; Risperidone; Saccades; Schizophrenia; Young Adult | 2013 |
Modulatory effects of ketamine, risperidone and lamotrigine on resting brain perfusion in healthy human subjects.
Topics: Adult; Brain; Dopamine Antagonists; Double-Blind Method; Excitatory Amino Acid Antagonists; Glutamic Acid; Healthy Volunteers; Humans; Ketamine; Lamotrigine; Male; Receptors, N-Methyl-D-Aspartate; Risperidone; Triazines; Young Adult | 2015 |
24 other study(ies) available for risperidone and ketamine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism.
Topics: Animals; Antipsychotic Agents; Autoradiography; Benzodiazepines; Brain; Brain Chemistry; Clozapine; Deoxyglucose; Excitatory Amino Acid Antagonists; Ketamine; Male; Olanzapine; Pirenzepine; Rats; Rats, Sprague-Dawley; Risperidone | 2000 |
Memantine, an NMDA antagonist, prevents the development of hyperthermia in an animal model for serotonin syndrome.
Topics: 5-Hydroxytryptophan; Animals; Body Temperature; Clorgyline; Disease Models, Animal; Dizocilpine Maleate; Drug Interactions; Excitatory Amino Acid Antagonists; Fever; Hypothalamus; Ketamine; Male; Memantine; Microdialysis; Norepinephrine; Rats; Rats, Wistar; Risperidone; Serotonin; Serotonin Antagonists; Serotonin Syndrome; Time Factors | 2004 |
(+/-) Ketamine-induced prepulse inhibition deficits of an acoustic startle response in rats are not reversed by antipsychotics.
Topics: Animals; Antipsychotic Agents; Clozapine; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Glutamic Acid; Haloperidol; Ketamine; Lamotrigine; Male; Pyridines; Rats; Rats, Sprague-Dawley; Reflex, Startle; Risperidone; Schizophrenia; Sulfonamides; Thiophenes; Triazines | 2007 |
Haloperidol and risperidone have specific effects on altered pain sensitivity in the ketamine model of schizophrenia.
Topics: Analgesics, Opioid; Animals; Antipsychotic Agents; Dose-Response Relationship, Drug; Electric Stimulation; Excitatory Amino Acid Antagonists; Haloperidol; Ketamine; Male; Morphine; Motor Activity; Pain; Pain Measurement; Rats; Rats, Sprague-Dawley; Risperidone; Schizophrenia; Schizophrenic Psychology | 2009 |
N-methyl-d-aspartic acid receptor antagonist-induced frequency oscillations in mice recreate pattern of electrophysiological deficits in schizophrenia.
Topics: Acoustic Stimulation; Amphetamine; Animals; Antipsychotic Agents; Biological Clocks; Central Nervous System Stimulants; Disease Models, Animal; Drug Interactions; Electroencephalography; Evoked Potentials, Auditory; Excitatory Amino Acid Antagonists; Haloperidol; Ketamine; Male; Mice; Mice, Inbred C57BL; Reaction Time; Risperidone; Schizophrenia | 2009 |
Effect of 'chronic' versus 'acute' ketamine administration and its 'withdrawal' effect on behavioural alterations in mice: implications for experimental psychosis.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Avoidance Learning; Behavior, Animal; Clozapine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Haloperidol; Ketamine; Male; Mice; Motor Activity; Psychotic Disorders; Random Allocation; Risperidone; Schizophrenia; Substance Withdrawal Syndrome; Swimming | 2011 |
Ketamine-enhanced immobility in forced swim test: a possible animal model for the negative symptoms of schizophrenia.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Clozapine; Disease Models, Animal; Female; Haloperidol; Immobility Response, Tonic; Ketamine; Male; Motor Activity; Rats; Rats, Wistar; Reproducibility of Results; Risperidone; Schizophrenia; Swimming | 2012 |
Prevention and reversal of ketamine-induced schizophrenia related behavior by minocycline in mice: Possible involvement of antioxidant and nitrergic pathways.
Topics: Animals; Antioxidants; Antipsychotic Agents; Corpus Striatum; Drug Therapy, Combination; Glutathione; Hippocampus; Ketamine; Male; Maze Learning; Mice; Minocycline; Motor Activity; Nitric Oxide; Nitrites; Prefrontal Cortex; Risperidone; Schizophrenia; Schizophrenic Psychology; Sensory Gating; Social Behavior; Thiobarbituric Acid Reactive Substances | 2013 |
Precompetitive consortium approach to validation of the next generation of biomarkers in schizophrenia.
Topics: Antipsychotic Agents; Biomarkers; Humans; Ketamine; Magnetic Resonance Imaging; Nicotine; Risperidone; Schizophrenia | 2014 |
Ketamine induces a robust whole-brain connectivity pattern that can be differentially modulated by drugs of different mechanism and clinical profile.
Topics: Adult; Brain; Brain Mapping; Cross-Over Studies; Dopamine Antagonists; Double-Blind Method; Excitatory Amino Acid Antagonists; Humans; Ketamine; Lamotrigine; Magnetic Resonance Imaging; Male; Receptors, N-Methyl-D-Aspartate; Risperidone; Triazines; Young Adult | 2015 |
Ketamine-induced brain activation in awake female nonhuman primates: a translational functional imaging model.
Topics: Animals; Antipsychotic Agents; Brain; Excitatory Amino Acid Antagonists; Female; Ketamine; Macaca mulatta; Magnetic Resonance Imaging; Receptors, N-Methyl-D-Aspartate; Risperidone; Wakefulness | 2016 |
Ketamine-induced changes in connectivity of functional brain networks in awake female nonhuman primates: a translational functional imaging model.
Topics: Animals; Antipsychotic Agents; Brain; Excitatory Amino Acid Antagonists; Female; Functional Neuroimaging; Ketamine; Macaca mulatta; Magnetic Resonance Imaging; Prefrontal Cortex; Risperidone; Wakefulness | 2016 |
Reversal of schizophrenia-like symptoms and immune alterations in mice by immunomodulatory drugs.
Topics: Animals; Antipsychotic Agents; Brain; Disease Models, Animal; Immunologic Factors; Immunomodulation; Interleukin-4; Interleukin-6; Ketamine; Male; Melatonin; Mice; Neuroimmunomodulation; Random Allocation; Risperidone; Schizophrenia; Schizophrenic Psychology; Tryptophan | 2017 |
Doxycycline prevents and reverses schizophrenic-like behaviors induced by ketamine in mice via modulation of oxidative, nitrergic and cholinergic pathways.
Topics: Acetylcholinesterase; Animals; Antipsychotic Agents; Catalase; Disease Models, Animal; Doxycycline; Excitatory Amino Acid Antagonists; Exploratory Behavior; Glutathione; Ketamine; Male; Malondialdehyde; Maze Learning; Mice; Nitroprusside; Oxidative Stress; Recognition, Psychology; Risperidone; Schizophrenia; Signal Transduction; Superoxide Dismutase | 2018 |
Involvement of GABAergic, BDNF and Nox-2 mechanisms in the prevention and reversal of ketamine-induced schizophrenia-like behavior by morin in mice.
Topics: Animals; Antioxidants; Behavioral Symptoms; Brain; Brain-Derived Neurotrophic Factor; Catalase; Disease Models, Animal; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Flavonoids; Haloperidol; Ketamine; Male; Memory, Short-Term; Mice; NADPH Oxidases; Risperidone; Schizophrenia; Stereotyped Behavior; Superoxide Dismutase; Swimming | 2018 |
A greater tendency for representation mediated learning in a ketamine mouse model of schizophrenia.
Topics: Amphetamine; Animals; Antipsychotic Agents; Central Nervous System Stimulants; Delusions; Disease Models, Animal; Feeding Behavior; Hallucinations; Ketamine; Learning; Male; Mice, Inbred C57BL; Motor Activity; Olfactory Perception; Risperidone; Schizophrenia; Schizophrenic Psychology | 2018 |
Effects of clozapine and risperidone antipsychotic drugs on the expression of CACNA1C and behavioral changes in rat 'Ketamine model of schizophrenia.
Topics: Animals; Antipsychotic Agents; Calcium Channels, L-Type; Clozapine; Cognition; Excitatory Amino Acid Antagonists; Hippocampus; Ketamine; Male; Maze Learning; Rats; Rats, Wistar; Risperidone; Schizophrenia; Social Behavior | 2022 |
Risperidone and ethyl pyruvate have protective effects against ketamine-induced cognitive impairments in mice.
Topics: Animals; Antipsychotic Agents; Cognitive Dysfunction; Ketamine; Mice; Pyruvates; Risperidone | 2022 |
Reversal and Preventive Pleiotropic Mechanisms Involved in the Antipsychotic-Like Effect of Taurine, an Essential β-Amino Acid in Ketamine-Induced Experimental Schizophrenia in Mice.
Topics: Amino Acids; Animals; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Dopamine; Interleukin-6; Ketamine; Mice; Risperidone; Schizophrenia; Serotonin; Taurine; Tumor Necrosis Factor-alpha | 2023 |